<unk> (Transdermal patch) is an antianginal drug that is FDA approved for the treatment of angina pectoris due to coronary artery disease.  The onset of action of transdermal<unk> is not sufficiently rapid for this product to be useful in aborting an acute attack.   Common adverse reactions include headache, lightheadedness and hypotension.
Nitroglycerin 
Nitroprusside
Endralazine
Imolamine
Amrinone
Papaverine
Adenosine
Nadolol 